MDLN · Medline Inc. · Held by Funds
Key customers — 74% of revenue (the year ended December 31, 2025)
“for the year ended December 31, 2025, approximately $19.7 billion (or 69% of consolidated net sales and 74% of U.S. net sales) was from sales to member hospitals under contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.”
Key customers — 69% of revenue (the year ended December 31, 2025)
“for the year ended December 31, 2025, approximately $19.7 billion (or 69% of consolidated net sales and 74% of U.S. net sales) was from sales to member hospitals under contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.”
5 customers — 11.3% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, our top five U.S. customers represented approximately $3.2 billion (or 11.3%) of our net sales.”
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of MDLN by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 3.72% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 0.62% | 8,091,429 |
| Index ETFs | 3.11% | 40,902,800 |
| Active ETFs | 0.06% | 792,687 |
| Active funds | 9.88% | 129,998,137 |
| Unclassified | 0.65% | 8,581,328 |
| All registered funds | 14.32% | 188,366,381 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding MDLN
384 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| AMCAP Fund | — | 18,780,959 | $657,896,994 | 0.70% | Long | 2026-08-31 | |
| Fidelity Contrafund | — | 14,031,409 | $553,398,771 | 0.31% | Long | 2026-06-30 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 12,406,857 | $489,326,440 | 0.02% | Long | 2026-06-30 | |
| Growth Fund of America | — | 13,853,297 | $485,280,994 | 0.14% | Long | 2026-08-31 | |
| VANGUARD MID-CAP INDEX FUND | — | 8,466,394 | $333,914,579 | 0.15% | Long | 2026-06-30 | |
| MFS Value Fund | — | 6,853,598 | $240,081,538 | 0.52% | Long | 2026-08-31 | |
| Janus Henderson Forty Fund | — | 5,908,950 | $233,048,988 | 0.98% | Long | 2026-06-30 | |
| Investment Co of America | — | 5,210,238 | $205,491,787 | 0.11% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 4,615,761 | $182,045,614 | 0.19% | Long | 2026-06-30 | |
| VANGUARD U.S. GROWTH FUND | — | 4,350,723 | $152,405,827 | 0.35% | Long | 2026-08-31 | |
| VANGUARD VALUE INDEX FUND | — | 3,715,953 | $146,557,186 | 0.06% | Long | 2026-06-30 | |
| MFS Growth Fund | — | 4,057,477 | $142,133,419 | 0.37% | Long | 2026-08-31 | |
| BlackRock Mid-Cap Growth Equity Portfolio | — | 3,344,265 | $117,149,603 | 2.43% | Long | 2026-08-31 | |
| Janus Henderson Enterprise Fund | — | 2,957,481 | $116,643,051 | 0.52% | Long | 2026-06-30 | |
| Fidelity Contrafund K6 | FLCNX | 2,948,399 | $116,284,857 | 0.31% | Long | 2026-06-30 | |
| Capital World Growth & Income Fund | — | 3,206,640 | $112,328,599 | 0.07% | Long | 2026-08-31 | |
| GROWTH PORTFOLIO | — | 2,776,624 | $109,510,051 | 3.05% | Long | 2026-06-30 | |
| VANGUARD MID-CAP VALUE INDEX FUND | — | 2,509,803 | $98,986,630 | 0.27% | Long | 2026-06-30 | |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | — | 2,438,449 | $96,172,429 | 0.42% | Long | 2026-06-30 | |
| MFS Mid Cap Growth Fund | — | 2,411,142 | $84,462,304 | 0.65% | Long | 2026-08-31 | |
| iShares Russell Mid-Cap ETF | IWR | 1,842,213 | $72,656,881 | 0.13% | Long | 2026-06-30 | |
| Invesco Main Street Fund | — | 1,827,579 | $71,787,303 | 0.62% | Long | 2026-07-31 | |
| Fidelity Extended Market Index Fund | FSMAX | 1,962,053 | $68,730,717 | 0.17% | Long | 2026-08-31 | |
| Fidelity Mid Cap Index Fund | FSMDX | 1,699,749 | $66,766,141 | 0.13% | Long | 2026-07-31 | |
| Fidelity Blue Chip Growth Fund | — | 1,698,871 | $66,731,653 | 0.07% | Long | 2026-07-31 | |
| MFS Mid Cap Value Fund | — | 1,660,206 | $65,478,525 | 0.38% | Long | 2026-06-30 | |
| Janus Henderson Contrarian Fund | — | 1,605,302 | $63,313,111 | 1.15% | Long | 2026-06-30 | |
| T. Rowe Price Blue Chip Growth Fund, Inc. | — | 1,575,818 | $62,150,262 | 0.10% | Long | 2026-06-30 | |
| Fidelity Puritan Fund | — | 1,693,159 | $59,311,360 | 0.18% | Long | 2026-08-31 | |
| Growth-Income Fund | — | 1,397,222 | $55,106,436 | 0.12% | Long | 2026-06-30 | |
| VIP Growth Portfolio | QVG2Q | 1,387,600 | $54,726,944 | 0.44% | Long | 2026-06-30 | |
| Fidelity Advisor New Insights Fund | — | 1,303,115 | $51,394,856 | 0.18% | Long | 2026-06-30 | |
| MidCap Fund | — | 1,285,369 | $50,489,294 | 0.22% | Long | 2026-07-31 | |
| Fidelity Advisor Equity Growth Fund | — | 1,347,108 | $47,189,193 | 0.36% | Long | 2026-08-31 | |
| Transamerica Capital Growth | — | 1,179,067 | $46,313,752 | 4.09% | Long | 2026-07-31 | |
| Fidelity Fund | — | 1,143,600 | $45,103,584 | 0.51% | Long | 2026-06-30 | |
| Invesco Discovery Mid Cap Growth Fund | — | 1,139,630 | $44,764,666 | 0.66% | Long | 2026-07-31 | |
| First Trust US Equity Opportunities ETF | FPX | 1,058,710 | $41,755,522 | 2.50% | Long | 2026-06-30 | |
| iShares Russell 1000 Value ETF | IWD | 1,003,926 | $39,594,841 | 0.05% | Long | 2026-06-30 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 1,127,431 | $39,493,908 | 0.18% | Long | 2026-08-31 | |
| Morgan Stanley Discovery Portfolio | — | 973,399 | $38,390,857 | 3.07% | Long | 2026-06-30 | |
| Fidelity Growth Company Fund | — | 1,049,822 | $36,775,265 | 0.04% | Long | 2026-08-31 | |
| VIP Contrafund Portfolio | — | 865,200 | $34,123,488 | 0.11% | Long | 2026-06-30 | |
| Janus Henderson Global Life Sciences Fund | — | 851,191 | $33,570,973 | 0.58% | Long | 2026-06-30 | |
| BlackRock High Yield Portfolio | — | 848,982 | $33,483,850 | 0.12% | Long | 2026-06-30 | |
| Parnassus Mid Cap Fund | — | 942,055 | $32,689,309 | 1.52% | Long | 2026-09-30 | |
| Fidelity Growth Discovery Fund | — | 750,200 | $29,587,888 | 0.44% | Long | 2026-06-30 | |
| Fidelity Series Opportunistic Insights Fund | FVWSX | 729,200 | $28,759,648 | 0.19% | Long | 2026-06-30 | |
| iShares Russell Mid-Cap Value ETF | IWS | 689,926 | $27,210,681 | 0.17% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 768,626 | $26,924,969 | 0.02% | Long | 2026-08-31 |